DXCM Investor Alert: DexCom Investigated by Bronstein, Gewirtz & Grossman, LLC

Investors who have suffered substantial losses due to investments in DexCom, Inc. may have the opportunity to lead a class-action lawsuit against the company, according to the law firm Bronstein, Gewirtz & Grossman, LLC. The class includes all individuals and entities that purchased or acquired DexCom securities between July 26, 2024, and September 17, 2025, inclusive. The lawsuit alleges that DexCom and certain officers violated federal securities laws by making false and misleading statements regarding the company’s business, operations, and compliance policies during the specified period.

Specifically, the complaint alleges that DexCom made unauthorized design changes to its G6 and G7 devices, which were not approved by the FDA. These changes allegedly made the devices less reliable and posed a significant health risk to users relying on them for accurate glucose readings. The defendants purportedly overstated the enhancements to the G7 device, its reliability, accuracy, and functionality, while downplaying the true extent of the issues and health risks associated with it. These actions exposed DexCom to increased regulatory scrutiny and enforcement actions, as well as potential legal, reputational, and financial damages.

A class-action lawsuit has already been filed, and investors interested in reviewing the complaint can do so on the law firm’s website. Those who suffered losses in DexCom have until December 26, 2025, to request to be appointed as lead plaintiff in the case. The law firm represents investors in class actions on a contingency fee basis, meaning they will only be reimbursed for expenses and attorneys’ fees if the case is successful and results in a recovery.

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that specializes in securities fraud class actions and shareholder derivative suits, having recovered hundreds of millions of dollars for investors across the country. Investors can stay updated on developments in the case by following the firm on various social media platforms. It’s important to note that prior results do not guarantee similar outcomes, and investors can contact the law firm for further information on the case.